Randomized, Double-blind, Placebo-Controlled, Efficacy Study of a New Formulation of Phenylephrine HCL in the Common Cold (PIER)

NCT03339726 PHASE2 TERMINATED Results posted

This will be a randomized, double-blind, placebo controlled, parallel-group Phase 2 study to evaluate the efficacy of a new formulation of phenylephrine HCl and a currently marketed phenylephrine HCl for relief of nasal congestion in subjects with naturally occurring cold symptoms.

Details

Lead sponsor	Johnson & Johnson Consumer Inc. (J&JCI)
Phase	PHASE2
Status	TERMINATED
Enrolment	193
Start date	Thu Nov 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Apr 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Common Cold

Interventions

• New Formulation Phenylephrine HCl
• Marketed Phenylephrine HCl
• Placebo

Countries

Canada